Ghent University Academic Bibliography

Mark

Targeted RNA-seq successfully identifies normal and pathogenic splicing events in breast/ovarian cancer susceptibility and Lynch syndrome genes

Rita D Brandão, Klaas Mensaert (UGent) , Irene López-Perolio, Demis Tserpelis, Markos Xenakis, Vanessa Lattimore, Logan C Walker, Anders Kvist, Ana Vega, Sara Gutiérrez-Enríquez, et al.

(2019) INTERNATIONAL JOURNAL OF CANCER.

Mark

Selective pharmacological inhibitors of HDAC6 reveal biochemical activity but functional tolerance in cancer models

Yves Depetter (UGent) , Silke Geurs (UGent) , Rob De Vreese (UGent) , Sophie Goethals (UGent) , Elien Vandoorn (UGent) , Alien Laevens, Jonas Steenbrugge (UGent) , Evelyne Meyer (UGent) , Pascal de Tullio, Marc Bracke (UGent) , et al.

(2019) INTERNATIONAL JOURNAL OF CANCER.

Mark

journalArticle

The influence of adjuvant systemic regimens on contralateral breast cancer risk and receptor subtype

Iris Kramer, Michael Schaapveld, Hester S A Oldenburg, Gabe S Sonke, Danielle McCool, Flora E van Leeuwen, Koen Van de Vijver (UGent) , Nicola S Russell, Sabine C Linn, Sabine Siesling, et al.

(2019) JNCI: Journal of the National Cancer Institute.

Mark

journalArticle
open access

Radiotherapy practice for paediatric brain tumours across Europe and quality assurance initiatives: Current situation, international survey and future perspectives

Teresa de Rojas, Enrico Clementel, Jordi Giralt, Ofelia Cruz, Tom Boterberg (UGent) , Rolf-Dieter Kortmann, Mark N. Gaze, Lucas Moreno and Geert O. Janssens

(2019) European Journal of Cancer. 114. p.36-46

Mark

Validation of hepatobiliary transport PET imaging in liver function assessment : evaluation of 3β-[18F]FCA in mouse models of liver disease

Stef De Lombaerde (UGent) , Lindsey Devisscher (UGent) , Jeroen Verhoeven (UGent) , Sara Neyt (UGent) , Hans Van Vlierberghe (UGent) , Christian Vanhove (UGent) and Filip De Vos (UGent)

(2019) NUCLEAR MEDICINE AND BIOLOGY.

Mark

ALK positively regulates MYCN activity through repression of HBP1 expression

Shana Claeys (UGent) , Geertrui Denecker, Kaat Durinck (UGent) , Bieke Decaesteker (UGent) , Liselot Mus (UGent) , Siebe Loontiens (UGent) , Suzanne Vanhauwaert (UGent) , Kristina Althoff, Caroline Wigerup, Daniel Bexell, et al.

(2019) ONCOGENE.

Mark

journalArticle
A1
open access

Boosting care and knowledge about hereditary cancer : European Reference Network on Genetic Tumour Risk Syndromes

Janet R Vos, Lisette Giepmans, Claas Röhl, Nicoline Geverink, Nicoline Hoogerbrugge, on behalf of ERN Genturis, Bruce Poppe (UGent) and Kathleen Claes (UGent)

(2019) FAMILIAL CANCER. 18(2). p.281-284

Mark

Granulocyte colony-stimulating factor and respiratory status of critically ill neutropenic patients with hematologic malignancies

Xavier Mignard, Lucie Biard, Virginie Lemiale, Djamel Mokart, Frédéric Pène, Achille Kouatchet, Julien Mayaux, François Vincent, Martine Nyunga, Fabrice Bruneel, et al.

(2019) LEUKEMIA & LYMPHOMA.

Mark

journalArticle

Complete remission for 4 years with crizotinib in advanced ALK-positive non-small cell lung cancer after thoracostomy for empyema

Eufra Van Damme, Maja Kiselinova and Elke Van Schoote

(2019) Tumori Journal.

Mark

Heterocellular 3D scaffolds as biomimetic to recapitulate the tumor microenvironment of peritoneal metastases in vitro and in vivo

Olivier De Wever (UGent) , Emiel De Jaeghere (UGent) and Elly De Vlieghere (UGent)

(2018) CANCER RESEARCH. 78(13, suppl.).

Academic Bibliography

Targeted RNA-seq successfully identifies normal and pathogenic splicing events in breast/ovarian cancer susceptibility and Lynch syndrome genes

Selective pharmacological inhibitors of HDAC6 reveal biochemical activity but functional tolerance in cancer models

The influence of adjuvant systemic regimens on contralateral breast cancer risk and receptor subtype

Radiotherapy practice for paediatric brain tumours across Europe and quality assurance initiatives: Current situation, international survey and future perspectives

Validation of hepatobiliary transport PET imaging in liver function assessment : evaluation of 3β-[18F]FCA in mouse models of liver disease

ALK positively regulates MYCN activity through repression of HBP1 expression

Boosting care and knowledge about hereditary cancer : European Reference Network on Genetic Tumour Risk Syndromes

Granulocyte colony-stimulating factor and respiratory status of critically ill neutropenic patients with hematologic malignancies

Complete remission for 4 years with crizotinib in advanced ALK-positive non-small cell lung cancer after thoracostomy for empyema

Heterocellular 3D scaffolds as biomimetic to recapitulate the tumor microenvironment of peritoneal metastases in vitro and in vivo

Contents

Support

Contact